While the world debates the virtues of private vs public healthcare, the GCC is busy pioneering medtech advances that transform lives. The healthcare industry in the GCC can be difficult to understand. On the one hand, the GCC is a high-income region financed with oil-revenues but on the other, it is still classed as developing…
A high-level delegation from business facilitation company Naseba invited for the Annual Investor Meeting of E-fung Capital, supporting deals in pharmaceuticals and portfolio companies DUBAI – With ambitions to boost private equity and venture capital investment in China, a high-level delegation from international business facilitation company Naseba, has attended the annual investor meeting of E-fung…
Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…
Actis, an investment firm specializing in growth markets, recently made a significant investment in Medis Group, a branded generic pharmaceuticals business based in North Africa. Medis was the first pharmaceutical company to launch sterile products in North Africa, and is responsible for building one of the first oncology laboratories on the continent. The company plans…
Recent figures from research and consulting firm GlobalData shows that the Saudi pharmaceutical market will grow from an estimated 4.5 billion USD in 2015 to a whopping 6 billion USD by 2020. Saudi Arabia already boasts one of the largest pharma markets in the Middle East, with population growth driving increasing demand for cutting-edge, efficient…
In a sign that China’s dedication to boosting its domestic healthcare industry remains as strong as ever, three Chinese investment firms have recently announced a 150 million USD investment in CStone Pharmaceuticals Co., Ltd., a bio-pharmaceutical company that is developing new treatments for major diseases. The research-based company was founded in Shanghai and Suzhou. Its…